Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-252-3 | CAS number: 56-04-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin Irritation:
In the in vitro skin corrosion test according to OECD 431 guideline, the test item showed tissue viability 92.23% after 240 min exposure. Thus, methylthiouracil is non-corrosive.
In the in vitro skin irritation test according to OECD 439 guideline the determined viability of culture treated by methylthiouracil (89.22%) fulfilled the criteria for non-irritancy.
Eye Irritation:
In vitro eye irritation test according to the OECD 437 guideline no prediction on classifiction cannot be made for eye irritation/serious eye damage or as causing serious eye damage
In the eye rritation test according to OECD 492 methylthiouracil showed a relative percent viability > 60 % . According to the criteria, it is concluded that the test item is non-irritant.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- GLP compliance:
- yes
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- EpiSkin from SkinEthic Laboratories France.
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 20 mg
- Duration of treatment / exposure:
- 3, 60 and 240 minutes
- Duration of post-treatment incubation (if applicable):
- 3 hour incubation with MTT
- Number of replicates:
- Two
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3 min exposure
- Value:
- 90.83
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60 min exposure
- Value:
- 96.64
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 240 min exposure
- Value:
- 92.23
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- he absolute mean OD570 of the negative control tissues was 0.9712, 0.8067 and 0.9037 for the 3 -minute, 60 -minute and 240 -minute exposures, respectively.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- After 240 -minute exposure in the Reconstructed Human Epidermis model the test item showed tissue viability 92.23%. Taken together, methylthiouracil is non-corrosive in the in vitro skin corrosion test performed according to OECD 431 guideline.
- Executive summary:
The test item, methylthiouracil, was tested for its possible skin corrosion potential using a three dimensional Reconstructed Human Epidermis model, EpiSkin, through topical application. The study was perfomed according to OECD 431 guideline. The absolute mean OD570 of the negative control tissues was 0.9712, 0.8067 and 0.9037 for the 3 -minute, 60 -minute and 240 -minute exposures, respectively. The positive control has a mean cell viability of 4.16 % after 240 -minute exposure. Thus, the results of the controls indicate that the test system functioned properly.
After 240 -minute exposure the test item showed tissue viability 92.23%. Taken together, the test item methylthiouracil is non-corrosive in the in vitro skin corrosion test.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- GLP compliance:
- yes
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
EpiSkin Small Model kit provided by SkinEthic
- Model used: EpiDerm™ (EPI-200-SIT)
- Tissue batch number(s): 17-EKIN-044
- Delivery date: 31 October , 2017 - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 10 mg
- Duration of treatment / exposure:
- 15 min
- Duration of post-treatment incubation (if applicable):
- 42 h
- Number of replicates:
- Three
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 15 min exposure
- Value:
- 89.22
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
In the in vitro skin irritation test according to OECD 439 guideline the determined viability of culture treated by methylthiouracil (89.22%) fulfilled the criteria for non-irritancy.- Executive summary:
The test item methylthiouracil was tested for its possible skin irritation potential using a three dimestional Reconstructed Human Epidermis model, EpiSkin. The test was performed according to OECD 439 guideline. The magnitude of viability was quantified by using MTT test. Validity of the test method was ascertained by positive control 5% SDS. Three tissue replicates were used for each treatment (exposure time 15 minutes), including negative and positive control.
The tissue viability met the acceptance criterion. Mean OD570of negative control was 0,7258. The viability of culture treated by positive control 5% SDS was 6.05%. The positive control met the acceptance criterion: mean tissue viability less than 20%. Determined viability of culture treated by methylthiouracil (89.22%) fulfilled the criteria for non-irritancy. Therefore, methylthiouracil is considered to be non-irritant to the skin.
Referenceopen allclose all
Mean OD values of individual epidermis units.
3 -minutes exposure
Adsorption (OD570) | ||
R1 | R2 | |
Negative control | 1,0449 | 0,9851 |
Test item |
0,9804 |
0,8715 |
60 -minutes exposure
Adsorption (OD570) | ||
R1 | R2 | |
Negative control | 0,8406 | 0,8605 |
Test item | 0,8172 | 0,8297 |
240 -minute exposure
Adsorption (OD570) | ||
Negative control | 0,9423 | 0,8527 |
Positive control | 0,0840 | 0,0788 |
Test item | 0,8786 | 0,8759 |
Table 1. True OD values of individual epidermis units.
Absorption (OD570) | |||||
R1 | R2 | R3 | Mean | SD | |
Negative control | 0,7248 | 0,7315 | 0,7210 | 0,7258 | 0,0053 |
Positive control | 0,0432 | 0,0433 | 0,0453 | 0,0439 | 0,0012 |
Test item | 0,6519 | 0,6398 | 0,6510 | 0,6476 | 0,0067 |
OD: optical density
R1, R2, R3:triplicate exposures
Ture OD value=OD Raw-OD Blank
Table 2. Individual tissue viability of epidermis units (relative).
% Individual viability | |||||
R1 | R2 | R3 | Mean | SD | |
Positive control | 5,95 | 5,96 | 6,24 | 6,05 | 0,17 |
Test item | 89,82 | 88,15 | 89,69 | 89,22 | 0,93 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- GLP compliance:
- yes
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Korde Chemicals Pvt. Ltd. / 151117
- Expiration date of the lot/batch: 14.11.2019
- Purity test date: 15.11.2017
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Ambient temperature
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: not specified
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: not specified
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing:
- Final preparation of a solid:
- Species:
- cattle
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Local abattoir (Slaughter house), Near Frazer town, Bengaluru
- Number of animals:
- Characteristics of donor animals (e.g. age, sex, weight):
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions):
- Time interval prior to initiating testing:
- indication of any existing defects or lesions in ocular tissue samples:
- Indication of any antibiotics used: - Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 100 mg
- Duration of treatment / exposure:
- 4 h
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
QUALITY CHECK OF THE ISOLATED CORNEAS
NUMBER OF REPLICATES
NEGATIVE CONTROL USED
SOLVENT CONTROL USED (if applicable)
POSITIVE CONTROL USED
APPLICATION DOSE AND EXPOSURE TIME
TREATMENT METHOD: [closed chamber / open chamber]
POST-INCUBATION PERIOD: yes/no. If YES please specify duration
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period:
- POST-EXPOSURE INCUBATION:
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity:
- Corneal permeability: passage of sodium fluorescein dye measured with the aid of [UV/VIS spectrophotometry / microtiter plate reader] (OD490)
- Others (e.g, pertinent visual observations, histopathology): (please specify)
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
DECISION CRITERIA: please specify if the decision criteria as indicated in the TG was used. - Irritation parameter:
- in vitro irritation score
- Value:
- 6.699
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- In conclusion, the test item 6-Methyl-2-Thiouracil cannot be predicted as not classified for eye irritation/serious eye damage or as causing serious eye damage with the BCOP test method.
- Executive summary:
The evaluation of the occular irritancy of methylthiouracil was carried out using the bovine corneal opacity and permeability assay (BCOP). 100 mg of test item was applied undiluted on the corneal surface by open chamber method. The IVIS scores were as follows: negative control (distilled water) 1.228, positive control (chlorhexidine) 163.377 and test item 6.699. The test item was classified as no prediction can be made based on UN GHS criteria.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- GLP compliance:
- yes
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Korde Chemicals pvt ltd RRR House, Plot 80, sector 23, Turbhe Cidco Industrial area Navi Mumbai-400705, India / 151117
- Expiration date of the lot/batch: 14.11.2019
- Purity test date: 15.11.2017
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Ambient (+15 to +25°C), avoid sunlight
- Stability under test conditions: stable
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability
Serious eye damage refers to the production of tissue damage in the eye, or serious physical decay of vision, following application of a test chemical to the anterior surface of the eye, which is not fully reversible within 21 days of application, as defined by the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (UN GHS).
The assessment of serious eye damage/eye irritation has typically involved the use of laboratory animals (OECD Test Guideline TG 405). In relation to animal welfare concerns, TG 405 recommends the use of a sequential testing strategy for the determination of the serious eye damage/eye irritation potential of chemicals. This testing strategy is described in a Supplement to the Guideline and includes the use of validated, scientifically valid and accepted in vitro test methods, thus decreasing or avoiding pain and suffering of animals. Most international regulation includes a requirement for in vitro tests for serious eye damage/eye irritation for substances manufactured or imported.
EpiOcular™ EIT is an in vitro test method able to correctly identify chemicals (both substances and mixtures) not requiring classification and labelling for eye irritation or serious eye damage according to UN GHS (1), and the test method was recommended as scientifically valid for the purpose.
One of the in vitro test method currently covered by this Test Guideline (OECD TG 492) is the EpiOcular™ Eye Irritation Test (EIT), which makes use of a commercially available RhCE tissue construct as test system.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live
The RhCE tissues come from Normal human epidermal keratinocytes (NHEK) derived from Neonatal-foreskin tissue. The tissues/cells are screened for: HIV, Hepatitis-B, Hepatitis-C, and mycoplasma.
Source of the Test System
MatTek Invitro Life Sciences Laboratories
Mlynske Nivy 73,
Bratislava, Slovakia.
EpiOcular tissues are produced by MatTek In vitro Life Sciences Laboratories and procured directly through world courier
Test System Cat No. Lot No Shipping Date Receipt Date
EpiOcular tissues OCL-200-EIT 27019 15 January 2018 16 January 2018 - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 mg - Duration of treatment / exposure:
- 6 h
- Duration of post- treatment incubation (in vitro):
- 17 h 47 m
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- - Details of the test procedure used
according to OECD 492
- RhCE tissue construct used, including batch number EpiOcular™ MatTek Invitro Life Sciences Laboratories Mlynske Nivy 73, Bratislava, Slovakia.
EpiOcular tissues are produced by MatTek In vitro Life Sciences Laboratories and procured directly through world courier.
Test System Cat No. Lot No Shipping Date Receipt Date
EpiOcular tissues OCL-200-EIT 27019 15 January 2018 16 January 2018
- Doses of test chemical and control substances used 50 μL each of negative control (sterile deionised water), positive control (methyl acetate) and 50 mg of test item
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable) post soak: After rinsing, the tissues were immediately transferred to a pre-labelled 12 well plate containing 5 mL of previously warmed assay medium, immersed and kept at room temperature for 22 minutes to facilitate the removal of any residue test item.
Post incubation: At the end of the Post-Soak immersion, each tissue was removed from the assay medium, the medium was decanted off the tissue, and the tissue construct was blotted on absorbent material.
The tissues were then transferred to a pre-labeled 6 well plate containing 1 mL of warm assay medium. The tissues were incubated for 17 hours and 47 minutes at 37oC, 5% Co2.
- Description of any modifications to the test procedure : none
- Description of the method used to quantify MTT formazan : according to OECD 492
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model
If the test item-treated tissue viability is > 60.0% relative to negative control-treated tissue viability, the test item is labeled as non-irritant.
If the test item-treated tissue viability is ≤ 60.0% relative to negative control-treated tissue viability, the test item is labeled as irritant.
- Complete supporting information for the specific RhCE tissue construct used
Serious eye damage refers to the production of tissue damage in the eye, or serious physical decay of vision, following application of a test chemical to the anterior surface of the eye, which is not fully reversible within 21 days of application, as defined by the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (UN GHS).
The assessment of serious eye damage/eye irritation has typically involved the use of laboratory animals (OECD Test Guideline TG 405). In relation to animal welfare concerns, TG 405 recommends the use of a sequential testing strategy for the determination of the serious eye damage/eye irritation potential of chemicals. This testing strategy is described in a Supplement to the Guideline and includes the use of validated, scientifically valid and accepted in vitro test methods, thus decreasing or avoiding pain and suffering of animals. Most international regulation includes a requirement for in vitro tests for serious eye damage/eye irritation for substances manufactured or imported.
EpiOcular™ EIT is an in vitro test method able to correctly identify chemicals (both substances and mixtures) not requiring classification and labelling for eye irritation or serious eye damage according to UN GHS (1), and the test method was recommended as scientifically valid for the purpose.
One of the in vitro test method currently covered by this Test Guideline (OECD TG 492) is the EpiOcular™ Eye Irritation Test (EIT), which makes use of a commercially available RhCE tissue construct as test system.
- Acceptable variability between tissue replicates for positive and negative controls
- Acceptable variability between tissue replicates for the test chemical
• The negative control OD was in between > 0.8 and < 2.5.
• The mean tissue viability of the positive control was < 50% compared to the negative control.
• The difference of viability between two tissue replicates were less than 20% for both the test item and positive control treated tissue, whereas for negative control treated tissues the difference of viability between two tissue replicates was greater than 20%. Since this variability will not have any impact on the outcome of test results, data was considered for further analysis and interpretation. - Irritation parameter:
- other: relative OD viability
- Run / experiment:
- Experiment
- Value:
- 100.41
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test method and test conditions employed the tissues treated with test item 6-Methyl-2-Thiouracil showed a relative percent viability > 60 % hence, it is concluded that the test item 6-Methyl-2-Thiouracil was Non-Irritant (NI).
- Executive summary:
In vitro eye irritation test was carried out using Reconstructed Human Cornea-like Epithelium with an objective to evaluate Eye Irritation potential of the test item 6-Methyl-2-Thiouracil. Pre-checks were performed on 6-Methyl-2-Thiouracil to identify if the test item was a direct MTT reducers and/or colour interfering substance. Test item was found to be non- reducer of MTT and did not react with either water or isopropanol to result in colour formation.
EpiOcularTMtissues were procured from MatTek In Vitro Life Science Laboratories. Upon receipt, the tissues were equilibrated to room temperature for 15 minutes. Tissues were inspected for any air bubbles between the agarose gel and insert. Then the tissues were carefully removed from agarose, blotted to remove agarose sticking to the inserts and transferred into 6 well plate containing 1 mL of assay medium and incubated at 37°C, 5% Co2for 1 hour. After the incubation period assay medium was replaced with fresh assay medium and incubated at 37°C, 5% Co2overnight for 16 hours.
Following overnight incubation, tissues were pre-wetted with 20 μL of Ca++Mg++Free-DPBS and incubated at 37°C, 5% Co2for 30 minutes. After prewetting, 50 µL each of negative control (sterile deionized water) and positive control (Methyl Acetate), 50 mg of test item 6-Methyl-2-Thiouracil was added on to the tissue surface. All the treatments were carried in duplicates (2 EpiOcular tissues/treatment) and incubated at 37oC, 5% Co2for 6 hours.
Post treatment, all the tissues were made free of negative control, positive control and test item by rinsing with Ca++Mg++-free DPBS. Post rinsing, the tissues were dried by blotting on to the tissue paper and soaked in 5 mL of assay medium filled in 12 well plate and incubated further for 22 minutes at room temperature.
Post soaking in media, tissues were transferred to pre labelled 6 well plate containing 1 mL of assay medium and incubated at 37oC, 5% Co2for 17 hours 47 minutes.
After the recovery period, MTT assay was carried out by transferring inserts into a 24 well plate containing 0.3 mL of MTT solution and incubated at 37°C, 5% Co2for 180 minutes. The inserts were transferred to a pre labelled 6 well plate containing 1 mL of isopropanol.The plate was sealed and stored overnight at 2-8°C in the dark and on the next day, the plates were kept on orbital shaker for 2 hours 50 minutes to extract the MTT. After extraction, the tissue inserts were removed and the liquid within each insert was decanted in to the same well from where it is removed and 1 mL of isopropanol was added to the extract mixed and was quantified by optical density (OD) measurement at 570 nm. OD values were analyzed to calculate the relative percent viability of the tissues.
The relative percent viability of the tissues treated with the test item 6-Methyl-2-Thiouracil was 100.41 % considering the mean negative control as 100 % viability. Under the same conditions the positive control Methyl Acetate showed only 38.28 % viability confirming the sensitivity of the test system.
Classification of test items as irritants and non-irritants was carried according to prediction model described in study plan. Under the test method and test conditions employed the tissues treated with test item showed a relative percent viability > 60 % hence, it is concluded that the test item 6 -Methyl-2-Thiouracil was Non-Irritant (NI).
Referenceopen allclose all
Table 1. Opacity calculations of negative control.
Cornea nro. | Blank value Io (lux) | Pretreatment cornea reading I (lux) |
Initial opacity |
Post-treatment cornea reading I (lux) |
Final opacity |
Change of opacity |
Corrected opacity |
Mean opacity |
4 | 502 | 455 | 5 | 450 | 5 | 0 | na | 1 |
5 | 502 | 449 | 5 | 435 | 7 | 2 | na | 1 |
6 | 502 | 497 | 1 | 480 | 2 | 1 | na | 1 |
Table 2 . Opacity calculations of positive control.
Cornea nro. | Blank value Io (lux) | Pretreatment cornea reading I (lux) |
Initial opacity |
Post-treatment cornea reading I (lux) |
Final opacity |
Change of opacity |
Corrected opacity |
Mean opacity |
27 | 502 | 453 | 5 | 123 | 123 | 118 | 117 | 162,67 |
28 | 502 | 442 | 6 | 80 | 211 | 205 | 204 | 162,67 |
29 | 502 | 454 | 5 | 94 | 173 | 168 | 167 | 162,67 |
Table 3. Opacity calculations of test item, methylthiouracil.
Cornea nro. | Blank value Io (lux) | Pretreatment cornea reading I (lux) |
Initial opacity |
Post-treatment cornea reading I (lux) |
Final opacity |
Change of opacity |
Corrected opacity |
Mean opacity |
4 | 502 | 455 | 5 | 450 | 5 | 0 | na | 1 |
5 | 502 | 449 | 5 | 435 | 7 | 2 | na | 1 |
6 | 502 | 497 | 1 | 480 | 2 | 1 | na | 1 |
Calculations
· Mean OD value of the blankcontrol wells (ODBlk) were calculated for each experiment.
· Blank corrected valueswere obtained by subtracting ODBlkvalue from each OD value of the same experiment.
· Mean value of the two aliquotsof each tissue were calculated to get corrected test item OD.
· Mean value of two relating tissueswere calculated to obtain the corrected mean OD.
Corrected OD value of negative control corresponds to 100% viability.
Corrected negative control OD = Negative control OD - ODBlk= 100% Viability
Calcultaion for viablity
Percentage viability was calculated for two relating tissues of controls and test item relative to the negative control (100 %).
Viability % = |
corrected test item OD |
x 100 |
|||
corrected mean negative control OD |
Mean test item viability was calculated and the test item was classified according to the prediction model, described in section 8.5.
Results
Code | Viability Tissue 1 | Viability Tissue 2 | Mean | Diff | Classifi- | |||||
cation | ||||||||||
Ali 1 | Ali 2 | Mean 1 | Ali 1 | Ali 2 | Mean 2 | 1 & 2 | 1 & 2 | |||
NC | 100.76 | 96.53 | 98.64 | 102.45 | 100.26 | 101.36 | 100 | 2.71 | NI | |
PC | 38.34 | 38.37 | 38.36 | 38.06 | 38.32 | 38.19 | 38.28 | 0.16 | I | |
Test item | 96.92 | 102.64 | 99.78 | 100.96 | 101.13 | 101.05 | 100.41 | 1.27 | NI |
NC: Negative Control (deionized water), PC: Positive control (methyl acetate), I: Irritant, NI: Non-irritant, Ali: Aliquot, Diff: difference of viability between 2 tissues.
OD Values of individual epiocular tissues
Treatment | OD570nm Values | |||
Tissue 1 | Tissue 2 | |||
R1 | R2 | R1 | R2 | |
Negative Control | 1.736 | 1.6649 | 1.7644 | 1.7277 |
Positive Control | 0.6859 | 0.6864 | 0.6812 | 0.6856 |
Test item (6-Methyl-2-Thiouracil) | 1.6715 | 1.7676 | 1.7394 | 1.7423 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The test item, methylthiouracil, was tested for its possible skin corrosion potential using a three dimensional Reconstructed Human Epidermis model, EpiSkin, through topical application. The study was perfomed according to OECD 431 guideline. The absolute mean OD570of the negative control tissues was 0.9712, 0.8067 and 0.9037 for the 3 -minute, 60 -minute and 240 -minute exposures, respectively. The positive control has a mean cell viability of 4.16 % after 240 -minute exposure. Thus, the results of the controls indicate that the test system functioned properly.
After 240 -minute exposure the test item showed tissue viability 92.23%. Taken together, the test item methylthiouracil is non-corrosive in the in vitro skin corrosion test.
The test item methylthiouracil was tested for its possible skin irritation potential using a three dimestional Reconstructed Human Epidermis model, EpiSkin. The test was performed according to OECD 439 guideline. The magnitude of viability was quantified by using MTT test. Validity of the test method was ascertained by positive control 5% SDS. Three tissue replicates were used for each treatment (exposure time 15 minutes), including negative and positive control.
The tissue viability met the acceptance criterion. Mean OD570of negative control was 0,7258. The viability of culture treated by positive control 5% SDS was 6.05%. The positive control met the acceptance criterion: mean tissue viability less than 20%. Determined viability of culture treated by methylthiouracil (89.22%) fulfilled the criteria for non-irritancy. Therefore, methylthiouracil is considered to be non-irritant to the skin.
The evaluation of the occular irritancy of methylthiouracil was carried out using the bovine corneal opacity and permeability assay (BCOP). 100 mg of test item was applied undiluted on the corneal surface by open chamber method. The IVIS scores were as follows: negative control (distilled water) 1.228, positive control (chlorhexidine) 163.377 and test item 6.699. The test item was classified as no prediction can be made based on UN GHS criteria.
The second test for eye irritation was performed according to OECD 492 guideline with Reconstructed Human Cornea-like epithelium (RhCE). The relative percent viability of the tissues treated with the test item 6-Methyl-2-Thiouracil was 100.41 % considering the mean negative control as 100 % viability. Under the same conditions the positive control Methyl Acetate showed only 38.28 % viability confirming the sensitivity of the test system.Classification of test items as irritants and non-irritants was carried according to prediction model described in study plan.Under the test method and test conditions employed the tissues treated with test item showed a relative percent viability > 60 % hence, it is concluded that the test item 6 -Methyl-2-Thiouracil was Non-Irritant (NI).
Justification for classification or non-classification
Skin Irritation:
The results of two key studies indicate that no classification is warranted for skin irritation according to CLP Regulation 1272/2008.
Eye Irritation
The results of two key studies do not indicate the test substance to be classified for eye irritant according to CLP Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.